This article explores the integral role of chemogenomics in modern phenotypic drug discovery (PDD), a biology-first approach responsible for a disproportionate number of first-in-class medicines.
This article provides a comprehensive overview of chemogenomic compound libraries, which are curated collections of small molecules designed to systematically probe families of biological targets.
This article provides a comprehensive overview of chemogenomics, an innovative strategy that integrates combinatorial chemistry, genomics, and proteomics to systematically identify and validate novel therapeutic targets and bioactive compounds.
This article provides a comprehensive guide to the basic principles of chemogenomic library design for researchers, scientists, and drug development professionals.
This article provides a comprehensive comparison of genetic and pharmacological strategies for targeting intrinsic resistance mechanisms in disease treatment.
This article provides a comprehensive framework for researchers, scientists, and drug development professionals on the validation of Epidemiological Cut-off (ECOFF) values and intrinsic resistance breakpoints.
This article provides a comprehensive comparative analysis of the intrinsic resistance mechanisms employed by ESKAPE pathogens—Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species.
Multidrug-resistant Gram-negative bacteria pose an urgent global health threat, with efflux pumps like AcrB playing a major role in antibiotic failure.
This article provides researchers, scientists, and drug development professionals with a comprehensive framework for distinguishing between intrinsic and phenotypic antimicrobial resistance (AMR).
This article provides a comprehensive resource for researchers and drug development professionals on validating the role of multidrug efflux pumps in intrinsic antibiotic resistance.